Innovative Blood Resources, Division Of New York Blood Center, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · May 11, 2022
  • No warning letters matched by name
Inspections 6 0 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 0 None on file

Innovative Blood Resources, Division Of New York Blood Center, Inc. has 0 FDA recalls, 6 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Innovative Blood Resources, Division Of New York Blood Center, Inc." is on file.

What these totals cover: FDA records filed under the name "Innovative Blood Resources, Division Of New York Blood Center, Inc." and its spelling variant "Innovative Blood Resources, Division Of New York Blood Center".

Latest inspection
May 11, 2022 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections6Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Innovative Blood Resources, Division Of New York Blood Center, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Innovative Blood Resources, Division Of New York Blood Center, Inc.: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202210000
202100000
202000000
201900000
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Innovative Blood Resources, Division Of New York Blood Center, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Innovative Blood Resources, Division Of New York Blood Center, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

6 inspections from Dec 3, 2009 to May 11, 2022.

DateSiteProductClassificationFEI
May 11, 2022Lincoln, NEBiologicsNo Action Indicated (NAI)3006339449
Oct 26, 2017Lincoln, NEBiologicsNo Action Indicated (NAI)3006339449
Feb 3, 2016Lincoln, NEBiologicsNo Action Indicated (NAI)3006339449
Mar 12, 2014Lincoln, NEBiologicsNo Action Indicated (NAI)3006339449
May 3, 2012Lincoln, NEBiologicsNo Action Indicated (NAI)3006339449
Dec 3, 2009Lincoln, NEBiologicsNo Action Indicated (NAI)3006339449
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3006339449Lincoln, NE6May 11, 2022

Innovative Blood Resources, Division Of New York Blood Center, Inc. and the FDA: common questions

Has Innovative Blood Resources, Division Of New York Blood Center, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Innovative Blood Resources, Division Of New York Blood Center, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Innovative Blood Resources, Division Of New York Blood Center, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Innovative Blood Resources, Division Of New York Blood Center, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Innovative Blood Resources, Division Of New York Blood Center, Inc.?

The most recent FDA inspection on file ended May 11, 2022 at Lincoln, NE and was classified NAI. FDA has 6 inspections of Innovative Blood Resources, Division Of New York Blood Center, Inc. on file.

Need more than this page shows? Ask about Innovative Blood Resources, Division Of New York Blood Center, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.